Latest filing published 25 Sept 2015 for ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, €38k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -34.0%Entry US$6.20 · Close at T+365 US$4.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
REF Securities & Co.: trading record in brief
All filings by REF Securities & Co. on record concern Arrhythmia Research Technology Inc /DE/. Over a trading history stretching from 28 August 2015 to 31 August 2015, the count stands at 6 filings.
Market trades split into 2 purchases (€76k) and 4 sales (€2,205). Purchases outweigh sales by €73k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 25 September 2015, reports an open-market purchase of €38k in Arrhythmia Research Technology Inc /DE/. Filings reach the SEC (Form 4) feed a median of 28 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to REF Securities & Co.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,800 shares@ US$6.25Common Stock, $0.10 par value per shareSEC:0001604925-15-000003:0Canonical exit: 26 Nov 2015 (T+90)
- 100 shares@ US$6.20Common Stock, $0.10 par value per shareSEC:0001604925-15-000003:1
- 100 shares@ US$6.19Common Stock, $0.10 par value per shareSEC:0001604925-15-000003:2
3 of 3 declarations